Argenx Secures $1.1 Billion in Funding Following Successful CIDP Trial
-
Drug News
Argenx Secures $1.1 Billion in Funding Following Successful CIDP Trial
Following a significant breakthrough with its star drug Vyvgart Hytrulo, argenx, a biopharmaceutical company, has successfully raised over $1 billion…
Read More »
